Potentiation of small cell lung cancer-related SIADH by trifluoperazine

Eur J Respir Dis. 1987 Nov;71(5):450-4.

Abstract

The syndrome of inappropriate anti-diuretic hormone secretion (SIADH) is a feature of approximately 7% of cases of small cell lung cancer (SCLC). The elaboration of peptide hormones by this tumour is well recognised and cerebral oedema resulting from inappropriate ADH secretion may be a life-threatening complication of this illness, requiring prompt intervention. We report a patient with SCLC who presented with SIADH which worsened abruptly each time he was treated with trifluoperazine for a co-existing psychosis.

Publication types

  • Case Reports

MeSH terms

  • Carcinoma, Small Cell / metabolism*
  • Humans
  • Hyponatremia / chemically induced
  • Inappropriate ADH Syndrome / chemically induced*
  • Inappropriate ADH Syndrome / complications
  • Inappropriate ADH Syndrome / etiology
  • Lung Neoplasms / complications*
  • Lung Neoplasms / metabolism*
  • Male
  • Middle Aged
  • Psychotic Disorders / complications
  • Psychotic Disorders / drug therapy
  • Trifluoperazine / adverse effects*
  • Trifluoperazine / therapeutic use

Substances

  • Trifluoperazine